Nexus Finance
IE000KD0BZ68.SG Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | IE000KD0BZ68

TER

0.25%

Total Expense Ratio per year

Fund Size

$10380214687.31B

Assets under management

Holdings

117

Underlying equities

Dividend Yield

N/A

Accumulating

Performance Analysis

Based on selected timeframe (1D)

Top Performers - Upside

ROCHE I RO.SW
+5.15%
ROCHE PS ROP.SW
+5.14%
Amylyx Pharmaceuticals, Inc. AMLX
+4.66%

Top Performers - Downside

Tempus AI, Inc. TEM
-7.22%
Celcuity Inc. CELC
-6.47%
Legend Biotech Corporation LEGN
-5.57%

Top Contributors - Upside

ROCHE PS ROP.SW • Weight: 3.64% • Perf: +5.14%
+0.19% Impact
LONZA N LONN.SW • Weight: 4.08% • Perf: +1.08%
+0.04% Impact
Vertex Pharmaceuticals Incorpor VRTX • Weight: 4.34% • Perf: +0.90%
+0.04% Impact

Top Contributors - Downside

Moderna, Inc. Weight: 4.66% • Perf: -5.17%
-0.24% Impact
Tempus AI, Inc. Weight: 1.10% • Perf: -7.22%
-0.08% Impact
Guardant Health, Inc. Weight: 3.86% • Perf: -1.91%
-0.07% Impact

ETF Profile

Provider Xtrackers
Region World
Country N/A
Sector Health Care
Strategy Social / Environmental
Theme Innovation
Distribution Policy Accumulating
Replication Full replication
Sustainable Yes

Aggregate Fundamentals

Weighted average of underlying holdings

Avg P/E Ratio 30.18
Avg Forward P/E 85.20

Growth Analysis

EPS Growth (LY->CY) -405.03%
Revenue Growth (LY->CY) +36.54%
EPS Growth (CY->NY) +35.00%
Revenue Growth (CY->NY) +185.48%
ende